Ginkgetin exerts its antitumor effects by modulating multiple oncogenic signaling cascades in tumor cells, notably the JAK/STAT, Wnt/β-catenin, AKT/GSK-3β, MAPK and ER pathway. This evidence concerns the gene AKT1 and neoplasm.